RHIV A Pilot Study Refractory or Intolerant to Highly Active Antiretroviral Therapy (HAART)

NCT00157027 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Atlantic Health System

Collaborators